Request that the FDA correct or remove statements describing % reduction in disability progression in the FDA table(s) titled FDA-approved treatments for relapsing multiple sclerosis, Approved treatments for relapsing MS, FDA Approved Treatments for Progressive Forms of MS | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-0775

Request that the FDA correct or remove statements describing % reduction in disability progression in the FDA table(s) titled FDA-approved treatments for relapsing multiple sclerosis, Approved treatments for relapsing MS, FDA Approved Treatments for Progressive Forms of MS

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensJan 27, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Interim Response Letter from FDA CDER to Kaylin Bower	Jul 17, 2026	--

Keywords

CDER

Citizen Petition

Correct or remove statements

describing % reduction in disability progression

FDA-approved treatments for

relapsing multiple sclerosis

Approved treatments for relapsing MS

FDA Approved Treatments for

Data from Regulations.gov